190 related articles for article (PubMed ID: 34963738)
1. Orosomucoid in liver diseases.
Elpek GO
World J Gastroenterol; 2021 Dec; 27(45):7739-7747. PubMed ID: 34963738
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
3. Orosomucoid system: 17 additional orosomucoid variants and proposal for a new nomenclature.
Yuasa I; Weidinger S; Umetsu K; Suenaga K; Ishimoto G; Eap BC; Duche JC; Baumann P
Vox Sang; 1993; 64(1):47-55. PubMed ID: 8447119
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies.
Liang J; Zhu J; Wang M; Singal AG; Odewole M; Kagan S; Renteria V; Liu S; Parikh ND; Lubman DM
Sci Rep; 2019 Aug; 9(1):11580. PubMed ID: 31399619
[TBL] [Abstract][Full Text] [Related]
5. Orosomucoid (ORM) typing by isoelectric focusing: evidence for several new variants including ORM1 and ORM2 silent alleles.
Yuasa I; Umetsu K; Suenaga K; Ikebuchi J; Suzuki T
Vox Sang; 1990; 58(2):129-34. PubMed ID: 2339522
[TBL] [Abstract][Full Text] [Related]
6. Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.
Zhan Z; Guan Y; Mew K; Zeng W; Peng M; Hu P; Yang Y; Lu Y; Ren H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G305-G312. PubMed ID: 31736338
[TBL] [Abstract][Full Text] [Related]
7. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.
Fang T; Cui M; Sun J; Ge C; Zhao F; Zhang L; Tian H; Zhang L; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li H; Li J
Oncotarget; 2015 Jun; 6(18):16106-19. PubMed ID: 25965830
[TBL] [Abstract][Full Text] [Related]
8. An Easy and Useful Noninvasive Score Based on α-1-acid Glycoprotein and C-Reactive Protein for Diagnosis of Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection.
Omran MM; Emran TM; Farid K; Eltaweel FM; Omar MA; Bazeed FB
J Immunoassay Immunochem; 2016; 37(3):273-88. PubMed ID: 26685049
[TBL] [Abstract][Full Text] [Related]
9. Orosomucoid (ORM) typing by isoelectric focusing: evidence for an additional duplicated ORM1 locus haplotype and close linkage of two ORM loci.
Yuasa I; Umetsu K; Suenaga K
Am J Hum Genet; 1988 Aug; 43(2):165-9. PubMed ID: 3400642
[TBL] [Abstract][Full Text] [Related]
10. Orosomucoid (ORM) typing by isoelectric focusing: an analysis of ORM haplotypes.
Yuasa I; Umetsu K; Suenaga K; Iha M; Hirata H; Ikebuchi J
Hum Hered; 1990; 40(5):267-71. PubMed ID: 2265852
[TBL] [Abstract][Full Text] [Related]
11. Distal promoter regions are responsible for differential regulation of human orosomucoid-1 and -2 gene expression and acute phase responses.
Sai K; Kurose K; Koizumi T; Katori N; Sawada J; Matsumura Y; Saijo N; Yamamoto N; Tamura T; Okuda H; Saito Y
Biol Pharm Bull; 2014; 37(1):164-8. PubMed ID: 24389491
[TBL] [Abstract][Full Text] [Related]
12. Orosomucoid (ORM) typing by isoelectric focusing: evidence of two structural loci ORM1 and ORM2.
Yuasa I; Umetsu K; Suenaga K; Robinet-Levy M
Hum Genet; 1986 Oct; 74(2):160-1. PubMed ID: 3770743
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients.
Katori N; Sai K; Saito Y; Fukushima-Uesaka H; Kurose K; Yomota C; Kawanishi T; Nishimaki-Mogami T; Naito M; Sawada J; Kunitoh H; Nokihara H; Sekine I; Ohe Y; Yoshida T; Matsumura Y; Saijo N; Yamamoto N; Okuda H; Tamura T
J Pharm Sci; 2011 Oct; 100(10):4546-59. PubMed ID: 21638284
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis.
Zhang D; Huang J; Luo D; Feng X; Liu Y; Liu Y
Biomark Med; 2017 May; 11(5):423-430. PubMed ID: 28621608
[TBL] [Abstract][Full Text] [Related]
15. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
Peta V; Zhu J; Lubman DM; Huguet S; Imbert-Bismutd F; Bolbach G; Clodic G; Matheron L; Ngo Y; Raluca P; Housset C; Rezai K; Poynard T;
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):681-691. PubMed ID: 31964615
[TBL] [Abstract][Full Text] [Related]
16. Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma.
He J; Zheng Z; Liu T; Ao Y; Yang Y; Hu H
Sci Rep; 2022 Sep; 12(1):15347. PubMed ID: 36096917
[TBL] [Abstract][Full Text] [Related]
17. Orosomucoid (ORM) typing by isoelectric focusing: evidence for gene duplication of ORM1 and genetic polymorphism of ORM2.
Yuasa I; Suenaga K; Umetsu K; Ito K; Robinet-Levy M
Hum Genet; 1987 Nov; 77(3):255-8. PubMed ID: 3679210
[TBL] [Abstract][Full Text] [Related]
18. ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma.
Gu J; Xu S; Chen X; Luo H; Tan G; Qi W; Ling F; Wang C; Maimaiti F; Chen Y; Yang L; Yin M; Chen D
Bosn J Basic Med Sci; 2022 Oct; 22(6):949-958. PubMed ID: 35765957
[TBL] [Abstract][Full Text] [Related]
19. N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma.
Fang M; Zhao YP; Zhou FG; Lu LG; Qi P; Wang H; Zhou K; Sun SH; Chen CY; Gao CF
Int J Cancer; 2010 Jul; 127(1):148-59. PubMed ID: 19904744
[TBL] [Abstract][Full Text] [Related]
20. Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS.
Kang X; Sun L; Guo K; Shu H; Yao J; Qin X; Liu Y
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1151-9. PubMed ID: 20130913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
